Is the English Cancer Patient Experience Survey representative? A comparative analysis with the National Lung Cancer Audit

被引:8
|
作者
Nartey, Yvonne [1 ]
Stewart, Iain [2 ]
Khakwani, Aamir [1 ]
Beattie, Vanessa [3 ]
Wilcock, Andrew [4 ,5 ]
Woolhouse, Ian [6 ]
Beckett, Paul [7 ]
Hubbard, Richard B. [1 ]
Tata, Laila J. [1 ]
机构
[1] Univ Nottingham, Nottingham City Hosp, Div Epidemiol & Publ Hlth, Clin Sci Bldg, Nottingham NG5 1PB, England
[2] Univ Nottingham, Nottingham City Hosp, Div Resp Med, Clin Sci Bldg, Nottingham NG5 1PB, England
[3] Aintree Univ Hosp NHS Fdn Trust, Longmoor Lane, Liverpool L9 7AL, Merseyside, England
[4] Nottingham Univ Hosp, Hayward House, Nottingham, England
[5] Univ Nottingham, Nottingham, England
[6] Queen Elizabeth Hosp Birmingham, Mindelsohn Way, Birmingham B15 2GW, W Midlands, England
[7] Univ Hosp Derby & Burton NHS Fdn Trust, Uttoxeter Rd, Derby DE22 3NE, England
关键词
Patient experience; Patient view; CPES; Lung cancer; England; EUROPE; 1999-2007; CARE; QUALITY; SURVIVAL; PATTERNS; NONRESPONSE; IMPACT;
D O I
10.1016/j.lungcan.2019.11.023
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: Healthcare systems increasingly recognise the importance of service users' perspectives for improving care organisation and delivery. The English Cancer Patient Experience Survey (CPES) is carried out annually, however, its representativeness within cancer types is unknown. We have explored if the CPES results are representative of people with lung cancer. Materials and methods: We linked cancer registry data across multiple sources to assess how CPES represents sociodemographic and clinical characteristics of the National Lung Cancer Audit population, accounting for post-sampling mortality bias. Multivariable logistic regression was used to compare people included and not included in CPES. Results: Of 240,375 people diagnosed (2009-2015), 15,967 (7 %) were included in CPES. Gender and ethnicity were reasonably represented, as were sociodemographic and clinical groupings, although more received anti-cancer treatment (96 % of CPES respondents vs. 56 % of patients nationally; adjusted odds ratio = 10.3, 95 confidence interval 9.4-11.2 for any anti-cancer treatment) with chemotherapy most over-represented, followed by surgery and then radiotherapy. CPES under-represented older, more socioeconomically deprived, and certain clinical groups, including those with worse performance status, multiple comorbidities, and diagnosis via emergency presentation. Conclusion: CPES includes patients across the sociodemographic and clinical spectrum indicating its value for research and service planning. Unbalanced representation of incident lung cancer cases is a limitation that must be considered in context of using CPES findings to implement service changes. Although half the national lung cancer population who received no anti-cancer treatment do not have their experiences represented, the strength of this dataset is in providing detailed comparisons of patient experiences across different treatment groups.
引用
收藏
页码:27 / 34
页数:8
相关论文
共 50 条
  • [21] Pre-referral general practitioner consultations and subsequent experience of cancer care: evidence from the English Cancer Patient Experience Survey
    Mendonca, S. C.
    Abel, G. A.
    Saunders, C. L.
    Wardle, J.
    Lyratzopoulos, G.
    EUROPEAN JOURNAL OF CANCER CARE, 2016, 25 (03) : 478 - 490
  • [22] Inequalities in reported cancer patient experience by socio-demographic characteristic and cancer site: evidence from respondents to the English Cancer Patient Experience Survey
    Saunders, C. L.
    Abel, G. A.
    Lyratzopoulos, G.
    EUROPEAN JOURNAL OF CANCER CARE, 2015, 24 (01) : 85 - 98
  • [23] Lung cancer multidisciplinary team meetings: A survey of participants at a national conference
    Bydder, S.
    Hasani, A.
    Broderick, C.
    Semmens, J.
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2010, 54 (02) : 146 - 151
  • [24] Lung Cancer Patients' Support Preferences: Insights from a Global Patient Experience Survey
    Clayton, K.
    Daniels, M.
    Fox, J.
    Gaspar, B.
    Hennink, M.
    Mayans, J.
    McNamara, A.
    Pretorius, L.
    Rigney, M.
    Dohr, M.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S285 - S286
  • [25] Lung cancer survival in England: trends in non-small-cell lung cancer survival over the duration of the National Lung Cancer Audit
    Khakwani, A.
    Rich, A. L.
    Powell, H. A.
    Tata, L. J.
    Stanley, R. A.
    Baldwin, D. R.
    Duffy, J. P.
    Hubbard, R. B.
    BRITISH JOURNAL OF CANCER, 2013, 109 (08) : 2058 - 2065
  • [26] Lung cancer survival in England: trends in non-small-cell lung cancer survival over the duration of the National Lung Cancer Audit
    A Khakwani
    A L Rich
    H A Powell
    L J Tata
    R A Stanley
    D R Baldwin
    J P Duffy
    R B Hubbard
    British Journal of Cancer, 2013, 109 : 2058 - 2065
  • [27] National trends in the quality of segmentectomy for lung cancer
    Logan, Charles D.
    Jacobs, Ryan C.
    Feinglass, Joe
    Lung, Kalvin
    Kim, Samuel
    Bharat, Ankit
    Odell, David D.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2023, 165 (01) : 351 - +
  • [28] Being assigned a clinical nurse specialist is associated with better experiences of cancer care: English population-based study using the linked National Cancer Patient Experience Survey and Cancer Registration Dataset
    Alessy, Saleh A.
    Luchtenborg, Margreet
    Rawlinson, Janette
    Baker, Matthew
    Davies, Elizabeth A.
    EUROPEAN JOURNAL OF CANCER CARE, 2021, 30 (06)
  • [29] Variation in reported experience of involvement in cancer treatment decision making: evidence from the National Cancer Patient Experience Survey
    A El Turabi
    G A Abel
    M Roland
    G Lyratzopoulos
    British Journal of Cancer, 2013, 109 : 780 - 787
  • [30] Evaluating the Success of the First Global Lung Cancer Coalition Patient Experience Survey
    Beattie, V.
    Rigney, M.
    O'Hagan, K.
    Boerckel, W.
    Hennink, M.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S468 - S469